Ultragenyx Pharmaceutical Inc. (FRA:UP0)
31.20
+2.60 (9.09%)
Last updated: Dec 4, 2025, 8:07 AM CET
Ultragenyx Pharmaceutical Market Cap
Ultragenyx Pharmaceutical has a market cap or net worth of €3.01 billion as of December 5, 2025. Its market cap has decreased by -21.20% in one year.
Market Cap
3.01B
Enterprise Value
3.38B
Revenue
537.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
€31.20
Market Cap Chart
Since January 31, 2014, Ultragenyx Pharmaceutical's market cap has increased from 909.66M to 3.01B, an increase of 231.07%. That is a compound annual growth rate of 10.63%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.06B |
| Siemens Aktiengesellschaft | 175.97B |
| Allianz SE | 141.37B |
| Deutsche Telekom AG | 131.00B |
| Siemens Energy AG | 98.87B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.10B |
| Rheinmetall AG | 68.36B |
| Deutsche Bank Aktiengesellschaft | 59.35B |